Tandem Diabetes Care Inc (TNDM) — Cash Flow Reinvestment Rate
Tandem Diabetes Care Inc (TNDM) has a Cash Flow Reinvestment Rate of 17.68x as of March 2026, reinvesting $195.45 Million (capex $6.27 Million plus investments $-189.18 Million) from operating cash flow of $11.05 Million. See Tandem Diabetes Care Inc (TNDM) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Tandem Diabetes Care Inc Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Tandem Diabetes Care Inc across 5 annual periods. For the full cash flow conversion analysis, see TNDM operating cash flow.
Annual Cash Flow Reinvestment Rate for Tandem Diabetes Care Inc (2019–2024)
Year-by-year capital reinvestment analysis for Tandem Diabetes Care Inc. See Tandem Diabetes Care Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.76x | $42.71 Million | $24.23 Million | $19.23 Million | ▲ +32.3% |
| 2022 | 1.33x | $67.27 Million | $50.46 Million | $34.10 Million | ▼ -20.6% |
| 2021 | 1.68x | $186.88 Million | $111.36 Million | $23.51 Million | ▼ -86.0% |
| 2020 | 12.00x | $296.06 Million | $24.67 Million | $32.29 Million | ▲ +783.0% |
| 2019 | 1.36x | $56.95 Million | $41.91 Million | $19.54 Million | — |